| Primary |
| Hypothyroidism |
48.5% |
| Thyroid Disorder |
10.6% |
| Autoimmune Thyroiditis |
9.1% |
| Major Depression |
9.1% |
| Breast Cancer |
6.1% |
| Thyroid Cancer |
4.5% |
| Disease Progression |
3.0% |
| Anxiety |
1.5% |
| Fatigue |
1.5% |
| Insomnia |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Thyroid Hormone Replacement Therapy |
1.5% |
| Tri-iodothyronine Decreased |
1.5% |
|
| Product Substitution Issue |
14.7% |
| Tremor |
8.8% |
| Urticaria |
8.8% |
| Abdominal Pain Upper |
5.9% |
| Constipation |
5.9% |
| Feeling Abnormal |
5.9% |
| Insomnia |
5.9% |
| Palpitations |
5.9% |
| Weight Increased |
5.9% |
| Alopecia |
2.9% |
| Amnesia |
2.9% |
| Blood Glucose Increased |
2.9% |
| Depression |
2.9% |
| Dermatitis Allergic |
2.9% |
| Diarrhoea |
2.9% |
| Drug Ineffective |
2.9% |
| Drug Interaction |
2.9% |
| Dyspepsia |
2.9% |
| Fatigue |
2.9% |
| Feeling Jittery |
2.9% |
|
| Secondary |
| Hypothyroidism |
22.7% |
| Thyroidectomy |
10.3% |
| Anxiety |
8.2% |
| Major Depression |
8.2% |
| Panic Attack |
6.2% |
| Weight Decreased |
6.2% |
| Depression |
5.2% |
| Fatigue |
5.2% |
| Toxicity To Various Agents |
4.6% |
| Weight Control |
4.1% |
| Drug Use For Unknown Indication |
3.1% |
| Hypertension |
2.6% |
| Thyroid Hormone Replacement Therapy |
2.6% |
| Thyroid Disorder |
2.1% |
| Ulcer |
2.1% |
| Oestrogen Replacement Therapy |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Sleep Disorder |
1.5% |
| Bipolar Disorder |
1.0% |
| Blood Cholesterol Increased |
1.0% |
|
| Weight Increased |
20.9% |
| Tension |
14.0% |
| Tremor |
9.3% |
| Urticaria |
7.0% |
| Drug Abuse |
4.7% |
| Psychomotor Hyperactivity |
4.7% |
| Tri-iodothyronine Increased |
4.7% |
| Tricuspid Valve Incompetence |
4.7% |
| Withdrawal Syndrome |
4.7% |
| Abdominal Discomfort |
2.3% |
| Anger |
2.3% |
| Arrhythmia |
2.3% |
| Cardiomyopathy |
2.3% |
| Completed Suicide |
2.3% |
| Constipation |
2.3% |
| Drug Ineffective |
2.3% |
| Feeling Abnormal |
2.3% |
| Feeling Jittery |
2.3% |
| Gait Disturbance |
2.3% |
| Oedema |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Drug Use For Unknown Indication |
17.0% |
| Hypothyroidism |
11.4% |
| Depression |
6.8% |
| Hypertension |
5.8% |
| Rheumatoid Arthritis |
5.1% |
| Thyroid Disorder |
4.8% |
| Osteoporosis |
3.3% |
| Pain |
3.3% |
| Vitamin Supplementation |
2.6% |
| Analgesic Therapy |
2.5% |
| Nausea |
2.4% |
| Asthma |
2.2% |
| Diabetes Mellitus |
2.2% |
| Chronic Sinusitis |
1.8% |
| Abdominal Discomfort |
1.6% |
| Bipolar Disorder |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Hypopituitarism |
1.6% |
| Insomnia |
1.6% |
|
| Weight Decreased |
16.5% |
| Pain |
6.3% |
| Vision Blurred |
6.3% |
| Colitis |
5.1% |
| Headache |
5.1% |
| Incorrect Dose Administered |
5.1% |
| Nasopharyngitis |
5.1% |
| Vomiting |
5.1% |
| Anaphylactic Reaction |
3.8% |
| Arthralgia |
3.8% |
| Depression |
3.8% |
| Diarrhoea |
3.8% |
| Injection Site Pain |
3.8% |
| Overdose |
3.8% |
| Palpitations |
3.8% |
| Personality Change |
3.8% |
| Pruritus |
3.8% |
| Stevens-johnson Syndrome |
3.8% |
| Suicidal Ideation |
3.8% |
| Tachycardia |
3.8% |
|
